Three dimensional pharmacophore models can be considered as an ensemble of steric and electronic features in space, which are necessary to ensure intermolecular interaction with a specific target in order to trigger or to block biological activity \[[@B1]\]. By identifying these features, a 3D pharmacophore model can be built in order to screen multi-conformatorial databases with the aim to detect compounds matching the pharmacophoric hypothesis and subsequently submit them to a biological testing. Even if a 3D crystal structure is at hand, the creation of a reliable pharmacophore model remains a challenging task.

CavKA (Cavity Knowledge Acceleration), our own in-house strategy employs the information of Co-crystallised ligand-receptor complexes for an automatic pharmacophore creation. Ligand features interacting with the binding site are detected and Grid \[[@B2]\] force field information is additionally taken into account as to weight and prioritize the identified features in question, to transform them into a pharmacophore model without any user intervention.

Our method is compared to LigandScout \[[@B3]\] and a custom MOE \[[@B4]\] implementation, similar to LigandScout, two powerful standard tools. Both are identifying ligand-receptor interactions to highlight important ligand features to be selected for creating pharmacophore models automatically. The performance is evaluated in a retrospective screening on the FieldScreen \[[@B5]\] dataset outlining strengths, weaknesses and as well as similarities of each method for the scrutinized targets.
